Requirement of gp130 signaling for the AGM hematopoiesis

Experimental Hematology

Volumn 31, Issue 4, 2003, Pages 283-289

  Takizawa, Makiko ^a,b   Nobuhisa, Ikuo ^a   Igarashi, Katsuhide ^c   Ueno, Masaya ^a,e   Nakashima, Kinichi ^a   Kitamura, Toshio ^d   Taga, Tetsuya ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b GUNMA UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GLYCOPROTEIN GP 130; PHENYLALANINE; STAT3 PROTEIN; STEM CELL FACTOR; YTTRIUM;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL LINEAGE; CELL POPULATION; CONTROLLED STUDY; DISSOCIATION; EMBRYO; EMBRYO CELL; FETUS CELL; GENE ACTIVATION; GENE EXPRESSION; GENE MUTATION; HEMATOPOIESIS; KNOCKOUT MOUSE; MOUSE; NONHUMAN; ONTOGENY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; RETROVIRUS; SIGNAL TRANSDUCTION; STEM CELL; WILD TYPE;

UNIDENTIFIED RETROVIRUS;

EID: 0037383580     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(03)00025-0     Document Type: Article

References (33)

1. Muller A.M., Medvinsky A., Strouboulis J., Grosveld F., Dzierzak E. Development of hematopoietic stem cell activity in the mouse embryo. Immunity. 1:1994;291-301.
2. Medvinsky A., Dzierzak E. Definitive hematopoiesis is autonomously initiated by the AGM region. Cell. 86:1996;897-906.
3. Matsuoka S., Tsuji K., Hisakawa H.et al. Generation of definitive hematopoietic stem cells from murine early yolk sac and paraaortic splanchnopleures by aorta-gonad-mesonephros region-derived stromal cells. Blood. 98:2001;6-12.
4. Ema H., Nakauchi H. Expansion of hematopoietic stem cells in the developing liver of a mouse embryo. Blood. 95:2000;2284-2288.
5. -/low cells capable of repopulating severe combined immunodeficiency mice. Blood. 94:1999;923-931.
6. Audet J., Miller C.L., Rose-John S., Piret J.M., Eaves C.J. Distinct role of gp130 activation in promoting self-renewal divisions by mitogenically stimulated murine hematopoietic stem cells. Proc Natl Acad Sci U S A. 98:2001;1757-1762.
7. Kawasaki K., Gao Y.H., Yokose S.et al. Osteoclasts are present in gp130-deficient mice. Endocrinology. 138:1997;4959-4965.
8. Yoshida K., Taga T., Saito M.et al. Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Proc Natl Acad Sci U S A. 93:1996;407-411.
9. Taga T., Kishimoto T. Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol. 15:1997;797-819.
10. Fukada T., Hibi M., Yamanaka Y.et al. Two signals are necessary for cell proliferation induced by a cytokine receptor gp130. involvement of STAT3 in anti-apoptosis Immunity. 5:1996;449-460.
11. Mukouyama Y., Chiba N., Mucenski M.L.et al. Hematopoietic cells in cultures of the murine embryonic aorta-gonad-mesonephros region are induced by c-Myb. Curr Biol. 9:1999;833-836.
12. Mukouyama Y., Hara T., Xu M.et al. In vitro expansion of murine multipotential hematopoietic progenitors from the embryonic aorta-gonad-mesonephros region. Immunity. 8:1998;105-114.
13. Takizawa T., Yanagisawa M., Ochiai W.et al. Directly linked soluble IL-6 receptor-IL-6 fusion protein induces astrocyte differentiation from neuroepithelial cells via activation of STAT3. Cytokine. 13:2001;272-279.
14. Murakami M., Narazaki M., Hibi M.et al. Critical cytoplasmic region of the interleukin 6 signal transducer gp130 is conserved in the cytokine receptor family. Proc Natl Acad Sci U S A. 88:1991;11349-11353.
15. Misawa K., Nosaka T., Morita S.et al. A method to identify cDNAs based on localization of green fluorescent protein fusion products. Proc Natl Acad Sci U S A. 97:2000;3062-3066.
16. Morita S., Kojima T., Kitamura T. Plat-E. an efficient and stable system for transient packaging of retroviruses Gene Ther. 7:2000;1063-1066.
17. Hibi M., Murakami M., Saito M., Hirano T., Taga T., Kishimoto T. Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell. 63:1990;1149-1157.
18. Minami M., Inoue M., Wei S.et al. STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line. Proc Natl Acad Sci U S A. 93:1996;3963-3966.
19. Kiuchi N., Nakajima K., Ichiba M.et al. STAT3 is required for the gp130-mediated full activation of the c-myc gene. J Exp Med. 189:1999;63-73.
20. Shirogane T., Fukada T., Muller J.M., Shima D.T., Hibi M., Hirano T. Synergistic roles for Pim-1 and c-Myc in STAT3-mediated cell cycle progression and antiapoptosis. Immunity. 11:1999;709-719.
21. Masuda M., Suzui M., Yasumatu R.et al. Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma. Cancer Res. 62:2002;3351-3355.
22. Mucenski M.L., McLain K., Kier A.B.et al. A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell. 65:1991;677-689.
23. Shivdasani R.A., Mayer E.L., Orkin S.H. Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL. Nature. 373:1995;432-434.
24. Porcher C., Swat W., Rockwell K., Fujiwara Y., Alt F.W., Orkin S.H. The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages. Cell. 86:1996;47-57.
25. Okuda T., van Deursen J., Hiebert S.W., Grosveld G., Downing J.R. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell. 84:1996;321-330.
26. Wang Q., Stacy T., Binder M., Marin-Padilla M., Sharpe A.H., Speck N.A. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc Natl Acad Sci U S A. 93:1996;3444-3449.
27. Ohtani T., Ishihara K., Atsumi T.et al. Dissection of signaling cascades through gp130 in vivo. reciprocal roles for STAT3- and SHP2-mediated signals in immune responses Immunity. 12:2000;95-105.
28. Nishida E., Gotoh Y. The MAP kinase cascade is essential for diverse signal transduction pathways. Trends Biochem Sci. 18:1993;128-131.
29. Davis R.J. The mitogen-activated protein kinase signal transduction pathway. J Biol Chem. 268:1993;14553-14556.
30. L'Allemain G., Pouyssegur J., Weber M.J. p42/mitogen-activated protein kinase as a converging target for different growth factor signaling pathways. use of pertussis toxin as a discrimination factor Cell Regul. 2:1991;675-684.
31. Lennartsson J., Blume-Jensen P., Hermanson M., Ponten E., Carlberg M., Ronnstrand L. Phosphorylation of Shc by Src family kinases is necessary for stem cell factor receptor/c-kit mediated activation of the Ras/MAP kinase pathway and c-fos induction. Oncogene. 18:1999;5546-5553.
32. Sengupta T.K., Talbot E.S., Scherle P.A., Ivashkiv L.B. Rapid inhibition of interleukin-6 signaling and Stat3 activation mediated by mitogen-activated protein kinases. Proc Natl Acad Sci U S A. 95:1998;11107-11112.
33. Jain N., Zhang T., Fong S.L., Lim C.P., Cao X. Repression of Stat3 activity by activation of mitogen-activated protein kinase (MAPK). Oncogene. 17:1998;3157-3167.